The latest financial statement is for the quarter ending 2025-12-31.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Net (loss) income | -875 | -5,545 | -3,516 |
| Depreciation and amortization | 1,203 | 1,146 | 1,062 |
| Allowance for content advances | -50 | -243 | - |
| Amortization of debt issuance costs | 31 | 83 | 75 |
| Stock-based compensation | 1,027 | 494 | 418 |
| Non-cash interest (income) expense | 0 | 372 | - |
| Barter transactions | -130 | -129 | 268 |
| Change in provision for credit losses | - | - | 99 |
| Capitalized content | 542 | 658 | 985 |
| Interest (discount) expense for term loan | - | - | 375 |
| Other | -59 | -273 | 126 |
| Employee retention tax credit | - | - | 0 |
| Accounts receivable | 3,960 | -2,527 | 412 |
| Content advances | -3,813 | -2,204 | -89 |
| Other current and long-term assets | -767 | 107 | 123 |
| Accounts payable, accrued expenses, and other liabilities | 4,451 | -3,098 | -10,022 |
| Interest expense for deferred consideration and earnouts | - | - | 3 |
| Deferred revenue | -41 | -50 | -84 |
| Net cash (used in) provided by operating activities | -1,613 | -7,171 | -14,524 |
| Expenditures for long-lived assets | 79 | 495 | 16 |
| Internally developed software capitalization | -498 | -165 | -181 |
| Sale of equity investment securities | 0 | 0 | 0 |
| Net cash used in investing activities | -577 | -841 | -16 |
| Proceeds from line of credit | 16,880 | 19,600 | 9,325 |
| Payments on line of credit | 15,244 | 16,583 | 5,697 |
| Proceeds from common stock warrant exercise | 0 | 5,843 | - |
| Withholding taxes paid on restricted stock units | 0 | 0 | 965 |
| Payment of deferred consideration | 0 | 464 | 95 |
| Proceeds from issuance of common stock from atm, net of fees | 636 | - | - |
| Payment of earnout consideration | 0 | 0 | - |
| Proceeds from the issuance of a term loan, net of debt issuance costs | 0 | 0 | 0 |
| Repayment of term loan | 0 | - | - |
| Cost to acquire treasury shares | 0 | 0 | 0 |
| Financing fees for line of credit | 0 | 0 | - |
| At-the-market issuance fees | 0 | 0 | 0 |
| Net cash provided by (used in) financing activities | 2,272 | 8,396 | 2,568 |
| Net change in cash and cash equivalents | 82 | 384 | -11,972 |
| Effect of exchange rate changes on cash | 43 | -17 | - |
| Cash and cash equivalents at beginning of period | 2,336 | 13,941 | - |
| Cash and cash equivalents at end of period | 2,461 | 2,336 | - |
Cineverse Corp. (CNVS)
Cineverse Corp. (CNVS)